Cargando…
Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation
BACKGROUND. Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease generally refractory to standard chemotherapeutic agents; therefore improvements in anticancer therapies are mandatory. A major determinant of therapeutic resistance in PDAC is the poor drug delivery to neoplastic cells, mainly...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Versita, Warsaw
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387991/ https://www.ncbi.nlm.nih.gov/pubmed/26029026 http://dx.doi.org/10.1515/raon-2015-0013 |